Trade

with

Harvard Bioscience Inc
(NASDAQ: HBIO)
AdChoices
4.72
+0.10
+2.16%
After Hours :
-
-
-

Open

4.66

Previous Close

4.62

Volume (Avg)

54.72k (57.80k)

Day's Range

4.65-4.73

52Wk Range

3.68-6.13

Market Cap.

149.21M

Dividend Rate ( Yield )

-

Beta

1.16

Shares Outstanding

32.30M

P/E Ratio (EPS)

104.17 (0.00)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 105.17M

    • Net Income

    • -1.83M

    • Market Cap.

    • 149.21M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 0.00

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.16

    • Forward P/E

    • -

    • Price/Sales

    • 1.45

    • Price/Book Value

    • 1.55

    • Price/Cash flow

    • 28.90

      • EBITDA

      • 5.28M

      • Return on Capital %

      • 0.00

      • Return on Equity %

      • 0.00

      • Return on Assets %

      • 0.00

      • Book Value/Share

      • 3.04

      • Shares Outstanding

      • 32.30M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -52.80

          • -15.59

          • Net Income

            Q/Q (last year)

          • 964.60

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 3.62

          • 12.51

          • Net Income

            5-Year Annual Average

          • -33.10

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 44.77

            • 52.83

            • Pre-Tax Margin

            • 1.02

            • 15.96

            • Net Profit Margin

            • 0.00

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 47.00

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 5.40

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 6.00

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.18

              • 0.62

              • Current Ratio

              • 3.93

              • 1.97

              • Quick Ratio

              • 2.77

              • 1.16

              • Interest Coverage

              • 1.99

              • 10.47

              • Leverage Ratio

              • 1.40

              • 2.38

              • Book Value/Share

              • 3.04

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 104.17

                • 34.60

                • P/E Ratio 5-Year High

                • 116.46

                • 279.76

                • P/E Ratio 5-Year Low

                • 55.17

                • 148.87

                • Price/Sales Ratio

                • 1.41

                • 3.21

                • Price/Book Value

                • 1.51

                • 4.00

                • Price/Cash Flow Ratio

                • 28.90

                • 16.67

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 0.00

                    (7.60)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 0.00

                    (5.50)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 0.59

                    (6.90)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 8.15

                  • 25.65k

                  • Inventory Turnover

                  • 3.30

                  • 2.66

                  • Asset Turnover

                  • 0.75

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.54M
                  Operating Margin
                  1.46
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  28.90
                  Ownership

                  Institutional Ownership

                  61.30%

                  Top 10 Institutions

                  32.79%

                  Mutual Fund Ownership

                  28.00%

                  Float

                  94.33%

                  5% / Insider Ownership

                  17.83%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Hussman Strategic Growth Fund

                  •  

                    930,000

                  • 0.00

                  • 2.88

                  • Vanguard US Discoveries Fund

                  •  

                    872,203

                  • 0.00

                  • 2.71

                  • Vanguard VIF Small Comp Gr

                  •  

                    595,200

                  • 0.00

                  • 1.85

                  • Vanguard Total Stock Mkt Idx

                  •  

                    450,862

                  • 1.39

                  • 1.40

                  • Vanguard Extended Market Index Fund

                  •  

                    427,391

                  • 0.59

                  • 1.32

                  • Royce Micro Cap Series Fund

                  •  

                    417,679

                  • -11.79

                  • 1.29

                  • F&C Global Smaller Companies

                  •  

                    410,222

                  • 0.00

                  • 1.27

                  • Jupiter US Smaller Companies

                  •  

                    376,619

                  • 0.00

                  • 1.18

                  • Mutual of America Small Cap Value

                  •  

                    346,235

                  • 0.00

                  • 1.07

                  • Royce Capital Fund Micro-Cap Portfolio

                  •  

                    345,268

                  • 19.28

                  • 1.07

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Granahan Investment Management Inc..

                  •  

                    1,644,590

                  • -3.72%

                  • 5.09

                  • Dimensional Fund Advisors, Inc.

                  •  

                    1,520,937

                  • +0.96%

                  • 4.72

                  • BlackRock Fund Advisors

                  •  

                    1,226,565

                  • -29.52%

                  • 3.80

                  • First Light Asset Management, LLC

                  •  

                    1,014,285

                  • +5.49%

                  • 3.15

                  • Jupiter Asset Management Limited

                  •  

                    991,019

                  • +163.14%

                  • 3.07

                  • Hussman Strategic Advisors, Inc.

                  •  

                    930,000

                  • 0.00%

                  • 2.89

                  • Vanguard Group, Inc.

                  •  

                    911,084

                  • -2.02%

                  • 2.83

                  • Royce & Associates, LLC

                  •  

                    767,100

                  • 0.00%

                  • 2.38

                  • Renaissance Technologies Corp

                  •  

                    740,400

                  • +26.66%

                  • 2.30

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Slow Growth

                  Style

                  Small Value

                  Harvard Bioscience, Inc. a Delaware corporation began in 1901. The Company is a developer, manufacturer and marketer of specialized products, like apparatus and scientific instruments, used to advance life science research at pharmac...moreeutical and biotechnology companies, universities and government laboratories. It has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain and sales facilities in France and Canada. It sells its products to researchers in over 100 countries mainly through its sales organization, catalog, website, distributors like GE Healthcare, Thermo Fisher Scientific Inc. and VWR, and via its field sales organization. Today, its broad product range is generally targeted towards two application areas; ADMET testing and molecular biology and liq...moreuid handling. ADMET Testing - The ADMET testing identifies compounds that have toxic side effects or undesirable physiological or pharmacological properties. It has products that its customers use to help their researchers conduct experiments on cells, tissues, organs and animals. The Company sells these products under the brand names including Harvard Pumps, Harvard Apparatus, Denville, Biochrom, Warner Instruments, BTX, KD Scientific, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, and CMA Microdialysis. These products are mainly scientific instruments such as spectrophotometers and plate readers that analyze light to detect and quantify molecular and cellular processes or apparatus such as gel electrophoresis units. The Company’s end-user customers are mainly research scientists at pharmaceutical and biotechnology companies, universities and government laboratories, including the U.S. National Institutes of Health, or NIH. The Company’s academic customers have included colleges and universities such as Baylor University, Cambridge University, Harvard University, Johns Hopkins University, Massachusetts Institute of Technology, Yale University and the University of Texas - MD Anderson Center. The Company’s pharmaceutical and biotechnological customers have included pharmaceutical companies and research laboratories such as Amgen, Inc., AstraZeneca plc, Genentech, Inc. and Johnson & Johnson. It competes with several companies that provide instruments for life science research including, Amaxa GmbH, Becton Dickinson, Eppendorf AG, Kent Scientific Corporation, Razel Scientific Instruments, Inc., Ugo Basile, Danaher Corporation, Bio-Rad Laboratories, Inc., MDS Analytical Technologies, PerkinElmer, Inc. and Thermo Fisher Scientific, Inc. The Company is not subject to direct governmental regulation other than the laws and regulations generally applicable to businesses in the domestic and foreign jurisdictions in which it operates.lessless

                  Key People

                  Mr. Jeffrey Duchemin

                  CEO/Director/President/Secretary

                  Earl R. Lewis

                  Director/Chairman of the Board

                  Mr. Robert E. Gagnon

                  CFO/Chief Accounting Officer/Secretary/Treasurer

                  Yong Sun

                  Vice President, Divisional

                  Yoav Sibony

                  Vice President, Divisional

                  • Harvard Bioscience Inc

                  • 84 October Hill Road

                  • Holliston, MA 01746

                  • USA.Map

                  • Phone: +1 508 893-8999

                  • Fax: +1 508 429-5732

                  • harvardbioscience.com

                  Incorporated

                  1901

                  Employees

                  368

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: